Compounds and methods of treating ocular disorders
US10568851B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2014 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Apr 25, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating an ocular disorder in a subject includes administering to the subject a therapeutically effective amount of an agent that modulates at least one target in a signaling cascade associated with light induced retinal degeneration, aberrant all-trans-retinal accumulation, and/or generation of reactive oxygen species (ROS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.